Chemotherapy-induced damage to ovary: mechanisms and clinical impact. (October 2016)

• Record Type: Journal Article
• Authors: Bedoschi, Giuliano; Navarro, Paula Andrea; Oktay, Kutluk
• Is Part Of: Future oncology. Volume 12:Number 19(2016)
• Page Start: 2333
• Page End: 2344
• Publication Date: 2016-10
• Subjects: anti-Mullerian hormone -- antral follicle count -- chemotherapy -- fertility preservation -- follicle-stimulating hormone -- ovarian aging -- ovarian damage -- ovarian reserve; Oncology -- Periodicals; 616.99405
• DOI: 10.2217/fon-2016-0176
• Languages: English
• ISSNs: 1479-6694

Abstract

Cancer is a major public health problem around the world. Currently, about 5% of women diagnosed with cancer are of reproductive age. These young survivors may face compromised fertility. The effects of chemotherapeutic agents on ovarian reserve and its clinical consequences are generally inferred from a variety of surrogate markers of ovarian reserve, all aiming to provide prognostic information on fertility or the likelihood of success of infertility treatment. Until recently, the mechanisms that are responsible for chemotherapy-induced ovarian damage were not fully elucidated. The understanding of these mechanisms may lead to targeted treatments to preserve fertility. In this manuscript, we will review the current knowledge on the mechanism of ovarian damage and clinical impact of chemotherapy agents on fertility.